John M. Skibber

Active 1985–2025

94
Papers
23,260
Citations
80
h-index
93
i10-index

Citations

Citations per year for John M. Skibber1981: 1 citations1986: 17 citations1987: 31 citations1988: 31 citations1989: 14 citations1990: 18 citations1991: 19 citations1992: 8 citations1993: 18 citations1994: 10 citations1995: 21 citations1996: 10 citations1997: 21 citations1998: 20 citations1999: 23 citations2000: 25 citations2001: 49 citations2002: 47 citations2003: 42 citations2004: 69 citations2005: 73 citations2006: 82 citations2007: 62 citations2008: 73 citations2009: 79 citations2010: 101 citations2011: 79 citations2012: 105 citations2013: 103 citations2014: 99 citations2015: 110 citations2016: 110 citations2017: 121 citations2018: 144 citations2019: 585 citations2020: 570 citations2021: 632 citations2022: 432 citations2023: 352 citations2024: 581 citations2025: 270 citations2026: 8 citations1982–1985: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 1,812 citing papers, 27.8% of this breakdownChina: 1,032 citing papers, 15.8% of this breakdownItaly: 371 citing papers, 5.7% of this breakdownUnited Kingdom: 299 citing papers, 4.6% of this breakdownJapan: 240 citing papers, 3.7% of this breakdownGermany: 239 citing papers, 3.7% of this breakdownNetherlands: 217 citing papers, 3.3% of this breakdownFrance: 214 citing papers, 3.3% of this breakdownSouth Korea: 198 citing papers, 3% of this breakdownSpain: 180 citing papers, 2.7% of this breakdownCanada: 170 citing papers, 2.6% of this breakdownAustralia: 160 citing papers, 2.4% of this breakdown
0%27.8%Other 21.4%

Fields

  • Medicine79.7%
  • Biochemistry, Genetics and Molecular Biology10%
  • Immunology and Microbiology6.3%
  • Computer Science0.8%
  • Engineering0.7%
  • Health Professions0.6%
  • Other1.9%

Topics

  • Colorectal Cancer Surgical Treatments12.3%
  • Colorectal and Anal Carcinomas7.5%
  • Colorectal Cancer Treatments and Studies6.1%
  • Colorectal Cancer Screening and Detection5.3%
  • Genetic factors in colorectal cancer4.3%
  • Cancer Immunotherapy and Biomarkers2.7%
  • Other61.8%

Coauthors

All papers

Open in search
  1. Colon Cancer, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Charles Schneider, David Shibata, John M. Skibber, Constantinos T. Sofocleous, Elena M. Stoffel, Eden Stotsky‐Himelfarb, Christopher G. Willett, Kristina M. Gregory, Lisa A. Gurski - Journal of the National Comprehensive Cancer Network 2021 cited by 1,748

  2. Rectal Cancer, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Leonard B. Saltz, Charles Schneider, David Shibata, John M. Skibber, Constantinos T. Sofocleous, Eden Stotsky‐Himelfarb, Anna Tavakkoli, Christopher G. Willett, Kristina M. Gregory, Lisa A. Gurski - Journal of the National Comprehensive Cancer Network 2022 cited by 819

  3. Increasing Disparities in the Age-Related Incidences of Colon and Rectal Cancers in the United States, 1975-2010

    Authors: , , , , , , , - JAMA Surgery 2014 cited by 1,099

  4. Observations on the Systemic Administration of Autologous Lymphokine-Activated Killer Cells and Recombinant Interleukin-2 to Patients with Metastatic Cancer

    Authors: , , , , , , , , , , , , - New England Journal of Medicine 1985 cited by 2,647

  5. Rectal Cancer, Version 2.2018, NCCN Clinical Practice Guidelines in Oncology

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Christopher G. Willett, Evan Wuthrick, Kristina M. Gregory, Lisa Gurski, Deborah A. Freedman-Cass - Journal of the National Comprehensive Cancer Network 2018 cited by 994

  6. NCCN Guidelines Insights: Colon Cancer, Version 2.2018

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Elena M. Stoffel, Eden Stotsky‐Himelfarb, Christopher G. Willett, Evan Wuthrick, Kristina M. Gregory, Deborah A. Freedman-Cass - Journal of the National Comprehensive Cancer Network 2018 cited by 1,029

  7. Colon Cancer, Version 3.2024, NCCN Clinical Practice Guidelines in Oncology

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Katrina S. Pedersen, Leonard B. Saltz, Charles Schneider, David Shibata, Benjamin D. Shogan, John M. Skibber, Constantinos T. Sofocleous, Anna Tavakkoli, Christopher G. Willett, Christina Wu, Lisa A. Gurski, Jenna Snedeker, Frankie Jones - Journal of the National Comprehensive Cancer Network 2024 cited by 308

  8. Overtreatment of Young Adults With Colon Cancer

    Authors: , , , , , , , , , - JAMA Surgery 2015 cited by 277

  9. NCCN Guidelines Insights: Rectal Cancer, Version 6.2020

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Constantinos T. Sofocleous, Elena M. Stoffel, Eden Stotsky‐Himelfarb, Christopher G. Willett, Alyse Johnson-Chilla, Lisa A. Gurski - Journal of the National Comprehensive Cancer Network 2020 cited by 500

  10. Colon Cancer, Version 1.2017, NCCN Clinical Practice Guidelines in Oncology

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Christina Wu, Kristina M. Gregory, Deborah A. Freedman-Cass - Journal of the National Comprehensive Cancer Network 2017 cited by 1,371

  11. NCCN Guidelines® Insights: Rectal Cancer, Version 3.2024

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Leonard B. Saltz, Charles Schneider, David Shibata, Benjamin D. Shogan, John M. Skibber, Constantinos T. Sofocleous, Anna Tavakkoli, Christopher G. Willett, Christina Wu, Frankie Jones, Lisa A. Gurski - Journal of the National Comprehensive Cancer Network 2024 cited by 215

  12. A phase II randomized double blinded trial evaluating the efficacy of curcumin with pre-operative chemoradiation for rectal cancer

    Authors: , , , , , , , , , , , , , , , , , , , - Journal of Gastrointestinal Oncology 2022 cited by 31

  13. Small Bowel Adenocarcinoma, Version 1.2020, NCCN Clinical Practice Guidelines in Oncology

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Constantinos T. Sofocleous, Elena M. Stoffel, Eden Stotsky‐Himelfarb, Christopher G. Willett, Alyse Johnson-Chilla, Kristina M. Gregory, Lisa A. Gurski - Journal of the National Comprehensive Cancer Network 2019 cited by 261

  14. Clinicopathology and Outcomes for Mucinous and Signet Ring Colorectal Adenocarcinoma: Analysis from the National Cancer Data Base

    Authors: , , , , , , , , - Annals of Surgical Oncology 2012 cited by 351

  15. Neoadjuvant Treatment Response As an Early Response Indicator for Patients With Rectal Cancer

    Authors: , , , , , , , , , , , - Journal of Clinical Oncology 2012 cited by 497

  16. En bloc resection of primary sacral tumors: classification of surgical approaches and outcome

    Authors: , , , , , , , , , - Journal of Neurosurgery Spine 2005 cited by 292

  17. Anal Carcinoma, Version 2.2023, NCCN Clinical Practice Guidelines in Oncology

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Katrina S. Pedersen, Leonard B. Saltz, Charles Schneider, David Shibata, John M. Skibber, Constantinos T. Sofocleous, Eden Stotsky‐Himelfarb, Anna Tavakkoli, Christopher G. Willett, Grant R. Williams, Frankie Algieri, Lisa A. Gurski, Katie Stehman - Journal of the National Comprehensive Cancer Network 2023 cited by 97

  18. Who Should Get Lateral Pelvic Lymph Node Dissection After Neoadjuvant Chemoradiation?

    Authors: , , , , , , , , , - Diseases of the Colon & Rectum 2019 cited by 112

  19. Colon Cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , - Journal of the National Comprehensive Cancer Network 2009 cited by 685

  20. Colon Cancer, Version 3.2014

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Deborah A. Freedman-Cass - Journal of the National Comprehensive Cancer Network 2014 cited by 221

  21. Functional Deficits and Symptoms of Long-Term Survivors of Colorectal Cancer Treated by Multimodality Therapy Differ by Age at Diagnosis

    Authors: , , , , , , , , - Journal of Gastrointestinal Surgery 2014 cited by 76

  22. Definitive Intensity-Modulated Chemoradiation for Anal Squamous Cell Carcinoma: Outcomes and Toxicity of 428 Patients Treated at a Single Institution

    Authors: , , , , , , , , , , , , , , , , , , , - The Oncologist 2022 cited by 21

  23. Tumor downstaging and sphincter preservation with preoperative chemoradiation in locally advanced rectal cancer: the M. D. Anderson Cancer Center experience

    Authors: , , , , , , , , , , , - International Journal of Radiation Oncology*Biology*Physics 1999 cited by 468

  24. Rectal Cancer, Version 2.2015

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Eden Stotsky‐Himelfarb, Christopher G. Willett, Kristina M. Gregory, Deborah A. Freedman-Cass - Journal of the National Comprehensive Cancer Network 2015 cited by 215